Rafał Zieliński

954 total citations
44 papers, 704 citations indexed

About

Rafał Zieliński is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Rafał Zieliński has authored 44 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Rafał Zieliński's work include Monoclonal and Polyclonal Antibodies Research (10 papers), HER2/EGFR in Cancer Research (5 papers) and Fungal and yeast genetics research (5 papers). Rafał Zieliński is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), HER2/EGFR in Cancer Research (5 papers) and Fungal and yeast genetics research (5 papers). Rafał Zieliński collaborates with scholars based in Poland, United States and Sweden. Rafał Zieliński's co-authors include Jacek Capala, Ilya Lyakhov, Gabriela Krämer-Marek, Amir Gandjbakhche, Moinuddin Hassan, David Zhang, Teresa M. Przytycka, Pawel F. Przytycki, Jie Zheng and Marcin Kozakiewicz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Bioinformatics and PLoS ONE.

In The Last Decade

Rafał Zieliński

42 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rafał Zieliński Poland 15 324 206 162 106 89 44 704
Youde Cao China 17 240 0.7× 150 0.7× 115 0.7× 293 2.8× 81 0.9× 46 871
Lars-Ivo Partecke Germany 16 204 0.6× 379 1.8× 180 1.1× 142 1.3× 179 2.0× 21 813
Jiale Qin China 17 264 0.8× 126 0.6× 110 0.7× 212 2.0× 45 0.5× 62 793
Malin Bern Norway 10 458 1.4× 377 1.8× 101 0.6× 47 0.4× 33 0.4× 12 776
Rosemarie ten Cate Netherlands 16 330 1.0× 131 0.6× 178 1.1× 196 1.8× 35 0.4× 25 659
Alexis Broisat France 18 342 1.1× 548 2.7× 144 0.9× 227 2.1× 159 1.8× 66 1.1k
Donald L. Siegel United States 10 259 0.8× 69 0.3× 214 1.3× 114 1.1× 24 0.3× 15 537
Kristin Støen Gunnarsen Norway 13 324 1.0× 345 1.7× 99 0.6× 24 0.2× 45 0.5× 14 680
Hironori Abe Japan 16 137 0.4× 100 0.5× 103 0.6× 184 1.7× 68 0.8× 39 637
Margherita Passariello Italy 14 219 0.7× 137 0.7× 305 1.9× 45 0.4× 33 0.4× 32 589

Countries citing papers authored by Rafał Zieliński

Since Specialization
Citations

This map shows the geographic impact of Rafał Zieliński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafał Zieliński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafał Zieliński more than expected).

Fields of papers citing papers by Rafał Zieliński

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafał Zieliński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafał Zieliński. The network helps show where Rafał Zieliński may publish in the future.

Co-authorship network of co-authors of Rafał Zieliński

This figure shows the co-authorship network connecting the top 25 collaborators of Rafał Zieliński. A scholar is included among the top collaborators of Rafał Zieliński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafał Zieliński. Rafał Zieliński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zieliński, Rafał, et al.. (2023). Anthracycline-induced cardiotoxicity — are we about to clear this hurdle?. European Journal of Cancer. 185. 94–104. 58 indexed citations
2.
Zieliński, Rafał, et al.. (2021). Otolaryngological procedures during the COVID-19 pandemic. SHILAP Revista de lepidopterología. 37(2). 140–144. 1 indexed citations
3.
Satpathy, Minati, Li‐Ya Wang, Rafał Zieliński, et al.. (2019). Targeted Drug Delivery and Image-Guided Therapy of Heterogeneous Ovarian Cancer Using HER2-Targeted Theranostic Nanoparticles. Theranostics. 9(3). 778–795. 80 indexed citations
4.
Zieliński, Rafał, Maria Respondek‐Liberska, & Stuart Weiner. (2018). Assessment of nasal and oral flow of amniotic fluid in 46 non-anomalous fetuses with sonographic and echocardiographic examination. Ginekologia Polska. 89(6). 316–320. 2 indexed citations
5.
Zieliński, Rafał, et al.. (2017). Classical versus custom orbital wall reconstruction: Selected factors regarding surgery and hospitalization. Journal of Cranio-Maxillofacial Surgery. 45(5). 710–715. 39 indexed citations
6.
Zieliński, Rafał & Maria Respondek‐Liberska. (2016). The role of prenatal ultrasound assessment in management of fetal cervicofacial tumors. Archives of Medical Science. 4(4). 850–855. 6 indexed citations
7.
Zieliński, Rafał, Józef Kobos, & Anna Zakrzewska. (2016). A case of intraparotid schwannoma in a juvenile: Clinical, pathological, ultrastructural, and immunohistopathological study, including an examination of Ki-67 and MCM-3 expressions. Ultrastructural Pathology. 40(4). 222–228. 1 indexed citations
8.
Zieliński, Rafał & Maria Respondek‐Liberska. (2015). Retrospective chart review of 44 fetuses with cervicofacial tumors in the sonographic assessment. International Journal of Pediatric Otorhinolaryngology. 79(3). 363–368. 5 indexed citations
9.
Krämer-Marek, Gabriela, Merel Gijsen, Dale O. Kiesewetter, et al.. (2012). Potential of PET to Predict the Response to Trastuzumab Treatment in an ErbB2-Positive Human Xenograft Tumor Model. Journal of Nuclear Medicine. 53(4). 629–637. 30 indexed citations
10.
Zieliński, Rafał, Moinuddin Hassan, Ilya Lyakhov, et al.. (2012). Affibody-DyLight Conjugates for In Vivo Assessment of HER2 Expression by Near-Infrared Optical Imaging. PLoS ONE. 7(7). e41016–e41016. 18 indexed citations
11.
Krämer-Marek, Gabriela, Marcelino Bernardo, Dale O. Kiesewetter, et al.. (2012). PET of HER2-Positive Pulmonary Metastases with 18F-ZHER2:342 Affibody in a Murine Model of Breast Cancer: Comparison with 18F-FDG. Journal of Nuclear Medicine. 53(6). 939–946. 30 indexed citations
12.
Zieliński, Rafał, Ilya Lyakhov, Moinuddin Hassan, et al.. (2011). HER2-Affitoxin: A Potent Therapeutic Agent for the Treatment of HER2-Overexpressing Tumors. Clinical Cancer Research. 17(15). 5071–5081. 48 indexed citations
13.
Zieliński, Rafał, et al.. (2011). Pneumomediastinum and emphysema in a case of a soft bronchial foreign body aspiration in a child. A case report. Otolaryngologia Polska. 65(1). 59–61. 3 indexed citations
15.
Zieliński, Rafał & Anna Zakrzewska. (2010). Ostre infekcje górnych dróg oddechowych u dzieci - podział morfologiczny, diagnostyka i terapia. Via Medica Journals. 4(5). 366–371.
16.
Lyakhov, Ilya, Rafał Zieliński, Gabriela Krämer-Marek, et al.. (2010). HER2‐ and EGFR‐Specific Affiprobes: Novel Recombinant Optical Probes for Cell Imaging. ChemBioChem. 11(3). 345–350. 32 indexed citations
17.
Chernomordik, Victor, Moinuddin Hassan, Sang Bong Lee, et al.. (2010). Quantitative Analysis of HER2 Receptor Expression In Vivo by Near-Infrared Optical Imaging. Molecular Imaging. 9(4). 192–200. 25 indexed citations
18.
Zieliński, Rafał, Ilya Lyakhov, Amy Jacobs, et al.. (2009). Affitoxin—A Novel Recombinant, HER2-specific, Anticancer Agent for Targeted Therapy of HER2-positive Tumors. Journal of Immunotherapy. 32(8). 817–825. 60 indexed citations
19.
Zieliński, Rafał, Pawel F. Przytycki, Jie Zheng, et al.. (2009). The crosstalk between EGF, IGF, and Insulin cell signaling pathways - computational and experimental analysis. BMC Systems Biology. 3(1). 88–88. 49 indexed citations
20.
Zieliński, Rafał. (1995). The effects of alcohol on neuropsychological functioning following head injury. Archives of Clinical Neuropsychology. 10(4). 409–410. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026